Pesquisas alternativas:
tool compared » model compared (Expandir a Pesquisa), tool compound (Expandir a Pesquisa), gel compared (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compared can (Expandir a Pesquisa), companies case (Expandir a Pesquisa)
aids compared » acids compared (Expandir a Pesquisa), areas compared (Expandir a Pesquisa), seeds compared (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
case new » cases new (Expandir a Pesquisa), cause new (Expandir a Pesquisa), caste new (Expandir a Pesquisa)
j test » j testa (Expandir a Pesquisa), j teat (Expandir a Pesquisa), j tett (Expandir a Pesquisa)
j tool » j topol (Expandir a Pesquisa), j toole (Expandir a Pesquisa)
3 aids » _ aids (Expandir a Pesquisa), a aids (Expandir a Pesquisa), 1 aids (Expandir a Pesquisa)
note » none (Expandir a Pesquisa), node (Expandir a Pesquisa)
tool compared » model compared (Expandir a Pesquisa), tool compound (Expandir a Pesquisa), gel compared (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compared can (Expandir a Pesquisa), companies case (Expandir a Pesquisa)
aids compared » acids compared (Expandir a Pesquisa), areas compared (Expandir a Pesquisa), seeds compared (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
case new » cases new (Expandir a Pesquisa), cause new (Expandir a Pesquisa), caste new (Expandir a Pesquisa)
j test » j testa (Expandir a Pesquisa), j teat (Expandir a Pesquisa), j tett (Expandir a Pesquisa)
j tool » j topol (Expandir a Pesquisa), j toole (Expandir a Pesquisa)
3 aids » _ aids (Expandir a Pesquisa), a aids (Expandir a Pesquisa), 1 aids (Expandir a Pesquisa)
note » none (Expandir a Pesquisa), node (Expandir a Pesquisa)
1
Publicado em 2014
“... from iTRAQ labeled samples, along with a number of cases illustrating the potential pitfalls above...”Obter o texto integral
Artigo
2
Publicado no Cell Prolif
(2002)
“...) and SPF (r = 0.77). P53 immunoreactivity was present in 71.4% of the tumours, whereas 39.3% of cases were...”Obter o texto integral
Obter o texto integral
Artigo